Effect of GH/IGF‐1 on bone metabolism and osteoporsosis

V Locatelli, VE Bianchi - International journal of endocrinology, 2014 - Wiley Online Library
Background. Growth hormone (GH) and insulin‐like growth factor (IGF‐1) are fundamental
in skeletal growth during puberty and bone health throughout life. GH increases tissue …

Growth hormone, insulin-like growth factors, and the skeleton

A Giustina, G Mazziotti, E Canalis - Endocrine reviews, 2008 - academic.oup.com
Abstract GH and IGF-I are important regulators of bone homeostasis and are central to the
achievement of normal longitudinal bone growth and bone mass. Although GH may act …

[HTML][HTML] Human conditions of insulin-like growth factor-I (IGF-I) deficiency

JE Puche, I Castilla-Cortázar - Journal of translational medicine, 2012 - Springer
Insulin-like growth factor I (IGF-I) is a polypeptide hormone produced mainly by the liver in
response to the endocrine GH stimulus, but it is also secreted by multiple tissues for …

Growth hormone, the insulin-like growth factor system, and the kidney

S Feld, R Hirschberg - Endocrine Reviews, 1996 - academic.oup.com
I. Introduction G ROWTH hormone and the insulin-like growth factors (IGFs) compile a
complex, interrelated system of three peptide hormones, GH, IGF-I, and IGF-II, their specific …

Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women

E Sienkiewicz, F Magkos, KN Aronis, M Brinkoetter… - Metabolism, 2011 - Elsevier
Strenuously exercising young women with hypothalamic amenorrhea are hypoleptinemic
and have low bone mineral density (BMD) and content (BMC), which predispose them to …

Instructional course lectures, the American Academy of Orthopaedic Surgeons-growth factors as therapeutic agents

SB Trippel, RD Coutts, TA Einhorn, GR Mundy… - JBJS, 1996 - journals.lww.com
Many of the diseases treated by orthopaedic surgeons reflect a failure of the function of
specific populations of cells. Skeletal deformities often stem directly or indirectly from the …

Skeletal effects of growth hormone and insulin-like growth factor-I therapy

RC Lindsey, S Mohan - Molecular and cellular endocrinology, 2016 - Elsevier
The growth hormone/insulin-like growth factor (GH/IGF) axis is critically important for the
regulation of bone formation, and deficiencies in this system have been shown to contribute …

Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis

AG Johansson, E Lindh, WF Blum… - The Journal of …, 1996 - academic.oup.com
Injections with growth hormone (GH) or insulin-like growth factor I (IGF-I) have been
proposed for anabolic therapy in osteoporosis. In a cross-over study, 12 men with idiopathic …

Somatomedin-1 (Recombinant Insulin-Like Growth Factor-1) clinical pharmacology and potential treatment of endocrine and metabolic disorders

Z Laron - BioDrugs, 1999 - Springer
Insulin-like growth factor (IGF-1) is a polypeptide of 70 amino acids. The circulatory form of
IGF-1 is synthesised in the liver. The metabolic activity of IGF-1 is regulated by 6 IGF-binding …

The anabolic effects of GH/IGF system on bone

Y Kasukawa, N Miyakoshi… - Current pharmaceutical …, 2004 - ingentaconnect.com
Osteoporosis is the result of imbalance in bone remodeling caused by increased bone
resorption and decreased bone formation. In terms of the mechanisms for the age-related …